Breaking News Instant updates and real-time market news.

PFE

Pfizer

$33.07

-0.06 (-0.18%)

09:00
10/13/16
10/13
09:00
10/13/16
09:00

Pfizer falls in pre-market trading

The stock was last down over 1.6% to $32.51 in the pre-market. At that price next support is at $31.25. Resistance is at $33.65. Jefferies earlier downgraded the stock to Hold, and reduced its price target to $36 from $39.

  • 01

    Nov

PFE Pfizer
$33.07

-0.06 (-0.18%)

08/23/16
RHCO
08/23/16
DOWNGRADE
RHCO
Neutral
Medivation downgraded to Neutral from Buy at SunTrust
Medivation (MDVN) has agreed to be acquired by Pfizer (PFE) for $81.50 per share.
09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
10/07/16
ROTH
10/07/16
NO CHANGE
Target $160
ROTH
Buy
ICU Medical price target raised to $160 from $132 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.
10/13/16
JEFF
10/13/16
DOWNGRADE
Target $36
JEFF
Hold
Pfizer downgraded to Hold from Buy at Jefferies
Jefferies analyst Jeffrey Holford downgraded Pfizer (PFE) to Hold citing a lack of positive catalysts. The analyst says the drivers for his upgrade to Buy have either played out or have not materialized, namely an inversion or GEP unit separation. To reflect the infusion business disposal and weaker Ibrance trends, Holford cut his mid-term earnings estimates for Pfizer by up to 7% and cut his price target for the shares to $36 from $39. The stock closed yesterday down 6c to $33.07. The analyst also sees increased risk of a major acquisition occurring over the next 12 months. In the global pharma space, Holford lists AbbVie (ABBV), Eli Lilly (LLY), Novartis (NVS) and AstraZeneca (AZN) as his top picks.

TODAY'S FREE FLY STORIES

NOV

National Oilwell

$37.91

-1.01 (-2.60%)

06:40
01/19/18
01/19
06:40
01/19/18
06:40
Hot Stocks
National Oilwell sees Q4 results at or above prior expectations »

National Oilwell Varco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

UDN

PowerShares DB US Dollar Index Down

$22.78

0.03 (0.13%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Hot Stocks
Synchrony reports Q4 net interest margin 16.24% compared to 16.26% last year »

Return on assets was 1.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PB

Prosperity Bancshares

$74.26

-0.2 (-0.27%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Prosperity Bancshares announces stock repurchase program »

Prosperity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 30

    Jan

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

, BIIB

Biogen

$344.44

-0.43 (-0.12%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Periodicals
Biogen among companies weighing bids for Acorda, Bloomberg reports »

Biogen (BIIB) and…

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

BIIB

Biogen

$344.44

-0.43 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Mar

SYF

Synchrony

$37.31

-0.75 (-1.97%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Synchrony reports estimated Common Equity Tier 1 ratio 16% »

The estimated Common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MRK

Merck

$61.13

-0.9 (-1.45%)

, AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Merck, AstraZeneca: LYNPARZA receives approval in Japan »

AstraZeneca (AZN) and…

MRK

Merck

$61.13

-0.9 (-1.45%)

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

GWR

Genesee & Wyoming

$81.57

0.18 (0.22%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Genesee & Wyoming reports December traffic 255,199 carloads, down 5,7% y/y »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Hot Stocks
Synchrony reports Q4 net interest income up 8% to $3.9B »

Loan receivables grew $6…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FHN

First Horizon

$20.21

-0.09 (-0.44%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Earnings
First Horizon reports Q4 EPS (20c) may not compare with consensus 30c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Periodicals
AstraZeneca sees big productivity jump amid fewer drug projects, Reuters reports »

AstraZeneca has seen an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

  • 08

    Mar

  • 23

    Apr

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Breaking Earnings news story on Wipro »

Wipro sees Q4 IT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Wipro reports Q3 revenue $2.1B, consensus $2.1B »

IT Services Segment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Hot Stocks
Breaking Hot Stocks news story on Citizens Financial »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

JAPAF

Japan Tobacco

$32.91

-0.29 (-0.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Upgrade
Japan Tobacco rating change  »

Japan Tobacco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:32
01/19/18
01/19
06:32
01/19/18
06:32
Hot Stocks
Citizens Financial raises quarterly dividend 22% to 22c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

PM

Philip Morris

$105.07

-0.72 (-0.68%)

, MO

Altria Group

$70.03

-0.12 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Upgrade
Philip Morris, Altria Group, British American Tobacco rating change  »

Philip Morris upgraded to…

PM

Philip Morris

$105.07

-0.72 (-0.68%)

MO

Altria Group

$70.03

-0.12 (-0.17%)

BTI

British American Tobacco

$68.56

-0.82 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Earnings
Citizens Financial reports Q4 EPS $1.35 with items, consensus 67c »

Reports Q4 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:30
01/19/18
01/19
06:30
01/19/18
06:30
Earnings
Breaking Earnings news story on Synchrony »

Synchrony reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MO

Altria Group

$70.03

-0.12 (-0.17%)

06:30
01/19/18
01/19
06:30
01/19/18
06:30
Upgrade
Altria Group rating change  »

Altria Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

JBHT

J.B. Hunt

$121.45

0.8 (0.66%)

06:28
01/19/18
01/19
06:28
01/19/18
06:28
Recommendations
J.B. Hunt analyst commentary  »

J.B. Hunt price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$27.68

0.175 (0.64%)

06:25
01/19/18
01/19
06:25
01/19/18
06:25
Periodicals
Emirates A380 order enables Airbus to maintain minimum production, Reuters says »

Emirates' recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$76.30

-0.28 (-0.37%)

, DAL

Delta Air Lines

$59.45

-0.27 (-0.45%)

06:23
01/19/18
01/19
06:23
01/19/18
06:23
Periodicals
United to offer premium economy on international flights, CNBC reports »

United Airlines (UAL) is…

UAL

United Continental

$76.30

-0.28 (-0.37%)

DAL

Delta Air Lines

$59.45

-0.27 (-0.45%)

AAL

American Airlines

$58.34

0.18 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 21

    Mar

LQ

La Quinta

$20.18

0.73 (3.75%)

, WYN

Wyndham

$122.73

5.6 (4.78%)

06:22
01/19/18
01/19
06:22
01/19/18
06:22
Recommendations
La Quinta, Wyndham analyst commentary  »

La Quinta price target…

LQ

La Quinta

$20.18

0.73 (3.75%)

WYN

Wyndham

$122.73

5.6 (4.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

GE

General Electric

$16.77

-0.58 (-3.34%)

06:19
01/19/18
01/19
06:19
01/19/18
06:19
Recommendations
General Electric analyst commentary  »

GE may be forced to raise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.